Article
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jan 2018
Kerr K M, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa J H, Marchetti A, Cheney R, Warth A, Speel E-J, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit E F, Dingemans A-M C, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger T R, Kammler R, Sumiyoshi T, Molina M A, Shames D S, Stahel R A, Peters S
Abstract excerpt
Background: Reported prevalence of driver gene mutations in non-small-cell lung cancer (NSCLC) is highly variable and clinical correlations are emerging. Using NSCLC biomaterial and clinical data from the European Thoracic Oncology Platform Lungscape iBiobank, we explore the epidemiology of mutat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.